HRSA 2023 Uniform Data System (UDS) Patient Level Submission (PLS) (UDS+) FHIR IG
1.1.0 - STU1 Release 1.1 - Standard for Trial-Use International flag

This page is part of the HRSA Uniform Data System (UDS) Patient Level Submission (PLS) (UDS+ or uds-plus) FHIR IG (v1.1.0: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Resource Profile: UDSPlusAllergyIntolerance - Mappings

Page standards status: Trial-use Maturity Level: 2

Mappings for the uds-plus-allergyintolerance resource profile.

Mappings for RIM Mapping (http://hl7.org/v3)

UDSPlusAllergyIntolerance
AllergyIntoleranceEntity. Role, or Act, Observation[classCode=OBS, moodCode=EVN]
   extensionN/A
   modifierExtensionN/A
   identifierid
   clinicalStatusObservation ACT .inboundRelationship[typeCode=COMP].source[classCode=OBS, code="clinicalStatus", moodCode=EVN].value
   verificationStatusObservation ACT .inboundRelationship[typeCode=COMP].source[classCode=OBS, code="verificationStatus", moodCode=EVN].value
   typecode
   categoryvalue < IntoleranceValue (Agent)
   criticalityinboundRelationship[typeCode=SUBJ].source[classCode=OBS, moodCode=EVN, code=SEV, value <= SeverityObservation (Severity Level)]
   codesubstance/product: .participation[typeCode=CAGNT].role[classCode=ADMM].player[classCode=MAT, determinerCode=KIND, code <= ExposureAgentEntityType] negated/excluded substance/product: .participation[typeCode=CAGNT, negationInd=true].role[classCode=ADMM].player[classCode=MAT, determinerCode=KIND, code <= ExposureAgentEntityType] positive or negated/excluded condition/situation: Observation.code=ASSERTION; Observation.value
   patient.participation[typeCode=SBJ].role[classCode=PAT]
      idn/a
      extensionn/a
      referenceN/A
      typeN/A
      identifier.identifier
   encounter.inboundRelationship[typeCode=COMP].source[classCode=ENC, moodCode=EVN]
      idn/a
      extensionn/a
      referenceN/A
      typeN/A
      identifier.identifier
   onset[x]effectiveTime.low
   recordedDate.participation[typeCode=AUT].time
   recorder.participation[typeCode=AUT].role
      idn/a
      extensionn/a
      referenceN/A
      typeN/A
      identifier.identifier
   asserter.participation[typeCode=INF].role
      idn/a
      extensionn/a
      referenceN/A
      typeN/A
      identifier.identifier
   lastOccurrenceoutBoundRelationship[typeCode=SUBJ].target[classCode=OBS, moodCode=EVN, code <= CommonClinicalObservationType, value <= ObservationValue (Reaction Type)].effectiveTime
   reactionoutBoundRelationship[typeCode=SUBJ].target[classCode=OBS, moodCode=EVN, code <= CommonClinicalObservationType, value <= ObservationValue (Reaction Type)]
      idn/a
      extensionn/a
      modifierExtensionN/A
      substanceoutBoundRelationship[typeCode=SAS].target[classCode=SBADM, code <= ExposureCode].participation[typeCode=CSM].role[classCode=ADMM].player[classCode=MAT, determinerCode=KIND, code <= ExposureAgentEntityType]
      manifestationcode
      descriptiontext
      onseteffectiveTime.low
      severityinboundRelationship[typeCode=SUBJ].source[classCode=OBS, moodCode=EVN, code=SEV, value <= SeverityObservation (Severity Level)]
      exposureRouteoutBoundRelationship[typeCode=SAS].target[classCode=SBADM, code <= ExposureCode].routeCode

Mappings for FiveWs Pattern Mapping (http://hl7.org/fhir/fivews)

UDSPlusAllergyIntolerance
AllergyIntolerance
   identifierFiveWs.identifier
   clinicalStatusFiveWs.status
   verificationStatusFiveWs.status
   typeFiveWs.class
   categoryFiveWs.class
   criticalityFiveWs.grade
   codeFiveWs.what[x]
   patientFiveWs.subject[x], FiveWs.subject
   encounterFiveWs.context
   onset[x]FiveWs.init
   recordedDateFiveWs.recorded
   recorderFiveWs.author
   asserterFiveWs.source

Mappings for HL7 v2 Mapping (http://hl7.org/v2)

UDSPlusAllergyIntolerance
AllergyIntolerance
   identifierIAM-7
   typeIAM-9
   categoryAL1-2
   criticalityAL1-4
   codeAL1-3 / IAM-3
   patient(PID-3)
   recordedDateIAM-13
   asserterIAM-14 (if patient) / IAM-18 (if practitioner)
   reaction
      manifestationAL1-5
      onsetAL1-6